0.25mg DRSP / 0.5mg E2 (BAY86-4891)

DRUG2 trials

Sponsors

Bayer

Conditions

Hot FlashesPostmenopauseVasomotor Symptoms

Phase 3

Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

CompletedNCT00446199

BayerHot Flashes, Vasomotor Symptoms

Start: 2007-03-31End: 2008-11-30Updated: 2015-05-06

Endometrial Safety Study

CompletedNCT00522873

BayerPostmenopause

Start: 2007-08-31End: 2009-08-31Updated: 2014-12-31